Literature DB >> 18307007

Hematoma-directed and ultrasound-guided breast-conserving surgery for nonpalpable breast cancer after Mammotome biopsy.

Hiroki Inui1, Masahiro Watatani, Yukihiko Hashimoto, Toshiya Hojo, Kyoko Hirai, Munehisa Yamato, Makoto Fujishima, Tatsuya Azumi, Hitoshi Shiozaki.   

Abstract

Stereotactic vacuum-assisted (Mammotome) breast biopsy is a powerful diagnostic tool for detecting microcalcifications on mammography, but it is difficult to remove the targeted lesion precisely when subsequent breast-conserving surgery is to be carried out. We achieved satisfactory results by performing hematoma-directed breast-conserving surgery after stereotactic Mammotome biopsy in seven patients. To identify the exact location of the Mammotome biopsy during the breast-conserving surgery, we created an iatrogenic hematoma in the biopsy cavity using patient's blood. This hematoma was detected easily on intraoperative ultrasonography in all patients, and was palpable as a soft mass in five of the seven patients. The microcalcifications were completely removed in all patients, and no cancer cells were found in the margin surfaces after breast-conserving surgery. There were no complications during the injection of the patient's blood into the biopsy cavity or during the hematoma-directed surgery. We describe this new procedure of hematoma-directed breast-conserving surgery following Mammotome biopsy for nonpalpable cancer with microcalcifications.

Entities:  

Mesh:

Year:  2008        PMID: 18307007     DOI: 10.1007/s00595-007-3595-4

Source DB:  PubMed          Journal:  Surg Today        ISSN: 0941-1291            Impact factor:   2.549


  9 in total

1.  Movement of a biopsy-site marker clip after completion of stereotactic directional vacuum-assisted breast biopsy: case report.

Authors:  E S Burnside; R E Sohlich; E A Sickles
Journal:  Radiology       Date:  2001-11       Impact factor: 11.105

2.  Hematoma-directed ultrasound-guided breast biopsy.

Authors:  L F Smith; R Henry-Tillman; S Harms; T Hronas; A T Mancino; K C Westbrook; S Korourian; M P Jones; V S Klimberg
Journal:  Ann Surg       Date:  2001-05       Impact factor: 12.969

3.  Tissue marking clip for stereotactic breast biopsy: initial placement accuracy, long-term stability, and usefulness as a guide for wire localization.

Authors:  F Burbank; N Forcier
Journal:  Radiology       Date:  1997-11       Impact factor: 11.105

4.  Performing a breast biopsy with a directional, vacuum-assisted biopsy instrument.

Authors:  S H Parker; A J Klaus
Journal:  Radiographics       Date:  1997 Sep-Oct       Impact factor: 5.333

5.  Intraoperative ultrasound localization of nonpalpable breast lesions.

Authors:  H C Snider; D G Morrison
Journal:  Ann Surg Oncol       Date:  1999 Apr-May       Impact factor: 5.344

6.  Clip migration after 11-gauge vacuum-assisted stereotactic biopsy: case report.

Authors:  Liane E Philpotts; Carol H Lee
Journal:  Radiology       Date:  2002-03       Impact factor: 11.105

7.  Stereotactic breast biopsy with a biopsy gun.

Authors:  S H Parker; J D Lovin; W E Jobe; J M Luethke; K D Hopper; W F Yakes; B J Burke
Journal:  Radiology       Date:  1990-09       Impact factor: 11.105

8.  Localization and needle aspiration of breast lesions: complications in 370 cases.

Authors:  M A Helvie; D M Ikeda; D D Adler
Journal:  AJR Am J Roentgenol       Date:  1991-10       Impact factor: 3.959

9.  Management of nonpalpable breast abnormalities.

Authors:  R E Symmonds; J W Roberts
Journal:  Ann Surg       Date:  1987-05       Impact factor: 12.969

  9 in total
  2 in total

1.  Evaluation of the Effects of Chitosan Hemostasis Dressings on Hemorrhage Caused by Breast Biopsy.

Authors:  Chen-Pin Chou; Yen-Chi Wang; Shwu Jen Chang; Pao-Hsin Liu; Shyh Ming Kuo
Journal:  Breast Care (Basel)       Date:  2012-06-22       Impact factor: 2.860

2.  Intraoperative indocyanine green fluorescence guidance for excision of nonpalpable breast cancer.

Authors:  Jintao Liu; Wenbin Guo; Meng Tong
Journal:  World J Surg Oncol       Date:  2016-10-18       Impact factor: 2.754

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.